These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7125091)

  • 1. [The place of lidocaine in the treatment of acute attacks of intracranial hypertension].
    Benoit P; Grimaud D; Melandri P; Maestracci P
    Agressologie; 1982; 23(C):43-6. PubMed ID: 7125091
    [No Abstract]   [Full Text] [Related]  

  • 2. Lidocaine or thiopental for rapid control of intracranial hypertension?
    Bedford RF; Persing JA; Pobereskin L; Butler A
    Anesth Analg; 1980 Jun; 59(6):435-7. PubMed ID: 7189982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of intravenous lidocaine in neuro-anesthesia and neuro-resuscitation].
    Artru F; Terrier A; Tixier S; Jourdan C; Deleuze R
    Agressologie; 1991; 32(8-9 Spec No):439-43. PubMed ID: 1844210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of beta-blockers in the treatment of idiopathic intracranial hypertension (physiopathogenetic basis)].
    Salvanet-Bouccara A; Mandelbaum-Stupp C
    J Fr Ophtalmol; 1985; 8(8-9):535-9. PubMed ID: 4086729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of mannitol, furosemide and mannitol with furosemide on intracranial pressure].
    Xu BN
    Zhonghua Wai Ke Za Zhi; 1988 Apr; 26(4):230-2, 255-6. PubMed ID: 3143525
    [No Abstract]   [Full Text] [Related]  

  • 6. Intracranial hypertension: barbiturate therapy and the role of the nurse.
    Ricci MM
    J Neurosurg Nurs; 1979 Dec; 11(4):247-52. PubMed ID: 260736
    [No Abstract]   [Full Text] [Related]  

  • 7. Barbiturate-augmented neurointensive care of intracranial hypertension in meningitis.
    Algren JT; Roe EJ
    J Ky Med Assoc; 1983 Mar; 81(3):158-61. PubMed ID: 6842052
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of propofol on intracranial pressure in patients without intracranial hypertension].
    Ravussin P; Thorin D; Guinard JP; Freeman J
    Ann Fr Anesth Reanim; 1989; 8 Suppl():R86. PubMed ID: 2604271
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mannitol treatment for increased intracranial pressure].
    Hansen PH; Rosenørn J; Westergaard L
    Ugeskr Laeger; 1983 Apr; 145(15):1125-7. PubMed ID: 6410563
    [No Abstract]   [Full Text] [Related]  

  • 10. [Benign intracranial hypertension].
    El Khamlichi A; Bellakhdar F; Ibrahimi A; El Ouarzazi ; Berbich A; Boukhrissi N; Bellakhdar N; Assamti O; Tamahmacht M
    Maghrib Tibbi; 1983 Mar; 5(1):1-125. PubMed ID: 6632969
    [No Abstract]   [Full Text] [Related]  

  • 11. [Monitoring intracranial pressure in pseudotumor cerebri. Apropos of 2 cases].
    Eizaguirre I; García Goicoechea M; García Goicoechia M; Albisu Y; Navajas B; Pérez-Yarza EG
    An Esp Pediatr; 1982 Jun; 16(6):520-3. PubMed ID: 7125404
    [No Abstract]   [Full Text] [Related]  

  • 12. [Complete cerebral ischemia in rabbits as a result of acute intracranial hypertension].
    Pluta R; Tołowa SW; Kapuściński A
    Neuropatol Pol; 1980; 18(3):365-84. PubMed ID: 7432637
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of multiple sclerosis and intracranial hypertension.
    Newman NJ; Selzer KA; Bell RA
    J Neuroophthalmol; 1994 Dec; 14(4):189-92. PubMed ID: 7881520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravenous treatment of intracranial hypertension and cerebral edema with stabilized solutions of glycerol-sodium ascorbate].
    Cantore GP; Battistini N; Neri L; Delfini R
    Boll Chim Farm; 1981 Jan; 120(1):32-42. PubMed ID: 7236370
    [No Abstract]   [Full Text] [Related]  

  • 15. Magnetic resonance imaging in pseudotumor cerebri.
    Brodsky MC; Vaphiades M
    Ophthalmology; 1998 Sep; 105(9):1686-93. PubMed ID: 9754178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical picture, diagnosis and rationale for the combined treatment of patients with an intracranial hypertension syndrome of nontumor origin. 1. The clinical characteristics of an intracranial hypertension syndrome of nontumor origin].
    Gabibov GA; Shakhnovich AR; Kornienko VN; Gasparian SS; Taniashin SV; Makhmudov UB; Kuklina AS; Shcherbakova EIa; Iurishchev EP; Vladimirova NA
    Zh Vopr Neirokhir Im N N Burdenko; 1994; (4):36-9. PubMed ID: 7900475
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study on reductions of intracranial pressure by therapeutic agents. I. The effects of mannitol through various methods of administration and the rebound phenomenon caused by the agent].
    Node Y
    Nihon Ika Daigaku Zasshi; 1982; 49(6):745-51. PubMed ID: 6820023
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical study on reductions of intracranial pressure by therapeutic agents. 2. Effects of glycerol through various administration methods and the rebound phenomenon caused by the agent].
    Node Y
    Nihon Ika Daigaku Zasshi; 1982; 49(6):752-8. PubMed ID: 7166584
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of lidocaine on intracranial hypertension.
    Brucia JJ; Owen DC; Rudy EB
    J Neurosci Nurs; 1992 Aug; 24(4):205-14. PubMed ID: 1517667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Water-electrolyte changes caused by osmotic diuretics and furosemide use in the treatment of intracranial hypertension].
    Di Giugno G; Mancini M; Orfei P; Rosa G; Tarquini S
    Minerva Anestesiol; 1984 Sep; 50(9):447-58. PubMed ID: 6442398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.